PL2866828T3 - Atenuowane szczepionki przeciwko streptococcus suis oraz sposoby ich wytwarzania i zastosowania - Google Patents

Atenuowane szczepionki przeciwko streptococcus suis oraz sposoby ich wytwarzania i zastosowania

Info

Publication number
PL2866828T3
PL2866828T3 PL13735511T PL13735511T PL2866828T3 PL 2866828 T3 PL2866828 T3 PL 2866828T3 PL 13735511 T PL13735511 T PL 13735511T PL 13735511 T PL13735511 T PL 13735511T PL 2866828 T3 PL2866828 T3 PL 2866828T3
Authority
PL
Poland
Prior art keywords
making
methods
streptococcus suis
attenuated streptococcus
suis vaccines
Prior art date
Application number
PL13735511T
Other languages
English (en)
Inventor
Russell F. Bey
Paulraj Kirubakaran Lawrence
Randy R. Simonson
Kamesh Reddy Sirigireddy
Danielle A. Mckeown
Original Assignee
Merial, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial, Inc. filed Critical Merial, Inc.
Publication of PL2866828T3 publication Critical patent/PL2866828T3/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
    • A61K39/092—Streptococcus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Pulmonology (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
PL13735511T 2012-06-27 2013-06-24 Atenuowane szczepionki przeciwko streptococcus suis oraz sposoby ich wytwarzania i zastosowania PL2866828T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201261664935P 2012-06-27 2012-06-27
EP13735511.1A EP2866828B1 (en) 2012-06-27 2013-06-24 Attenuated streptococcus suis vaccines and methods of making and use thereof
PCT/US2013/047282 WO2014004361A1 (en) 2012-06-27 2013-06-24 Attenuated streptococcus suis vaccines and methods of making and use thereof

Publications (1)

Publication Number Publication Date
PL2866828T3 true PL2866828T3 (pl) 2018-04-30

Family

ID=48782624

Family Applications (1)

Application Number Title Priority Date Filing Date
PL13735511T PL2866828T3 (pl) 2012-06-27 2013-06-24 Atenuowane szczepionki przeciwko streptococcus suis oraz sposoby ich wytwarzania i zastosowania

Country Status (18)

Country Link
US (1) US9289484B2 (pl)
EP (1) EP2866828B1 (pl)
JP (1) JP6262728B2 (pl)
KR (1) KR102126096B1 (pl)
CN (1) CN104780935B (pl)
AR (1) AR091582A1 (pl)
AU (2) AU2013280718B2 (pl)
BR (1) BR112014032636A2 (pl)
CA (1) CA2877817A1 (pl)
DK (1) DK2866828T3 (pl)
EA (1) EA036764B1 (pl)
ES (1) ES2662801T3 (pl)
MX (1) MX365879B (pl)
MY (1) MY173796A (pl)
NZ (1) NZ703701A (pl)
PH (1) PH12014502855B1 (pl)
PL (1) PL2866828T3 (pl)
WO (1) WO2014004361A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9132183B2 (en) * 2007-03-09 2015-09-15 Newport Laboratories Modified live (JMSO strain) Haemophilus parasuis vaccine
US10280199B2 (en) 2014-02-07 2019-05-07 Phibro Animal Health Corporation Coronavirus proteins and antigens
ES2942260T3 (es) 2014-09-14 2023-05-31 Tel Hashomer Medical Res Infrastructure & Services Ltd Ligandos sintéticos de receptores de somatostatina
CN105348373B (zh) * 2015-11-24 2019-01-11 武汉天种畜牧股份有限公司 猪链球菌血清3型的粘附性抗原ssust3_1962及其制备方法和应用
US10279031B2 (en) 2016-05-11 2019-05-07 Phibro Animal Health Corporation Composition comprising antigens and a mucosal adjuvant and a method for using
EP3454893A4 (en) * 2016-05-11 2020-01-01 Phibro Animal Health Corporation A composition comprising antigens and a mucosal adjuvant and a method for using
CA3054765A1 (en) 2017-03-15 2018-09-20 London School Of Hygiene And Tropical Medicine Whole cell vaccines
JP2020529408A (ja) * 2017-08-03 2020-10-08 インターベット インターナショナル ベー． フェー． ストレプトコッカス・スイスに対する防御のためのワクチン
CN111328289A (zh) * 2017-08-31 2020-06-23 勃林格殷格翰动物保健美国公司 预防生殖、育龄和生长猪的疾病的猪链球菌疫苗及其制备和使用方法
CN111447945A (zh) * 2017-12-15 2020-07-24 英特维特国际股份有限公司 用于保护以抗猪链球菌的疫苗
CN110327460A (zh) * 2019-06-05 2019-10-15 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 猪链球菌病-副猪嗜血杆菌病二联亚单位疫苗及制备方法
CN112694988B (zh) * 2020-12-15 2022-12-06 武汉市农业科学院 一种鸡源猪链球菌弱毒株及其应用
CN115161333B (zh) * 2022-06-23 2023-08-25 中国农业科学院哈尔滨兽医研究所（中国动物卫生与流行病学中心哈尔滨分中心） 一种猪链球菌的反向筛选标记、含有该反向筛选标记的猪链球菌及其应用
CN120399980B (zh) * 2025-06-30 2025-11-21 杭州依思康医药科技有限公司 猪链球菌2型荚膜多糖高产菌株及应用
CN120843391A (zh) * 2025-07-02 2025-10-28 华中农业大学 一种无乳链球菌弱毒株、疫苗及其应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3529056A (en) * 1968-05-07 1970-09-15 American Home Prod Method of producing jowl abscess vaccine
US4708871A (en) 1983-03-08 1987-11-24 Commonwealth Serum Laboratories Commission Antigenically active amino acid sequences
EP0930893B1 (en) 1996-10-11 2005-04-13 The Regents of The University of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
US5980912A (en) 1997-03-25 1999-11-09 Zonagen, Inc. Chitosan induced immunopotentiation
US6455323B1 (en) * 1997-07-03 2002-09-24 Pharmacia & Upjohn Company Anti-bacterial methods and materials
US6379676B2 (en) * 1999-03-10 2002-04-30 Anitox Corporation Enhancing immune response in animals
KR20040091698A (ko) * 2002-03-08 2004-10-28 쉐링-플라우 리미티드. 신규한 플로르페니콜형 항생제
JP4500615B2 (ja) * 2004-07-14 2010-07-14 日生研株式会社 エリシペロトリックス属のその他の菌種である血清型１８由来の豚丹毒菌感染防御活性を有する新規ポリペプチドとその遺伝子および製法
WO2007116322A2 (en) * 2006-02-17 2007-10-18 Novartis Ag Purification of bacterial antigens
BRPI1008561A2 (pt) * 2009-02-20 2018-07-24 Australian Poultry Crc Pty Ltd vacinas vivas atenuadas
KR101209964B1 (ko) * 2010-10-15 2012-12-07 주식회사 동방 돼지 다발성 장막염 예방용 백신 조성물 및 그 제조방법

Also Published As

Publication number Publication date
EA201500054A1 (ru) 2015-06-30
WO2014004361A1 (en) 2014-01-03
AR091582A1 (es) 2015-02-11
AU2016222520A1 (en) 2016-09-22
US9289484B2 (en) 2016-03-22
MY173796A (en) 2020-02-24
AU2013280718B2 (en) 2016-06-09
MX2015000045A (es) 2015-03-05
CN104780935A (zh) 2015-07-15
PH12014502855A1 (en) 2015-02-09
BR112014032636A2 (pt) 2017-08-29
KR20150033692A (ko) 2015-04-01
PH12014502855B1 (en) 2015-02-09
CA2877817A1 (en) 2014-01-03
US20140004144A1 (en) 2014-01-02
MX365879B (es) 2019-06-18
EP2866828A1 (en) 2015-05-06
HK1203834A1 (en) 2015-11-06
EP2866828B1 (en) 2017-12-13
AU2013280718A1 (en) 2015-02-12
KR102126096B1 (ko) 2020-06-23
JP2015522282A (ja) 2015-08-06
ES2662801T3 (es) 2018-04-09
EA036764B1 (ru) 2020-12-17
JP6262728B2 (ja) 2018-01-17
DK2866828T3 (en) 2018-01-15
CN104780935B (zh) 2018-01-02
AU2016222520B2 (en) 2018-03-22
NZ703701A (en) 2016-03-31

Similar Documents

Publication Publication Date Title
PL2866828T3 (pl) Atenuowane szczepionki przeciwko streptococcus suis oraz sposoby ich wytwarzania i zastosowania
ZA201501858B (en) Anti-mcam antibodies and associated methods of use
TWI560180B (en) Substituted benzamides and methods of use thereof
GB2535360B (en) Methods of preparing polyhemiaminals and polyhexahydrotriazines
SG10201609940RA (en) Compounds and their methods of use
ZA201408236B (en) Anti-ly6e antibodies and immunoconjugates and methods of use
IL241878B (en) Macrolides and methods for their preparation and use
SG11201502343RA (en) Cyclic ether pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
PT3725807T (pt) Anticorpos anti-cd47 e métodos de utilização destes
ZA201404675B (en) Anti-lrp5 antibodies and methods of use
SG11201502757QA (en) Anti-c16orf54 antibodies and methods of use thereof
LT2802325T (lt) Anesteziniai junginiai ir su jais susiję panaudojimo būdai
EP2806811A4 (en) VERTEBRAL CONSTRUCTION
SG11201507978XA (en) Vaccine composition and method of use
IL245529A0 (en) Rapidly disintegrating formulations and methods of use
PL2844275T3 (pl) Koagulazy gronkowcowe stanowiące antygeny i sposoby ich zastosowania
HUE036110T2 (hu) Legyengített sertésinfluenza vakcinák és eljárások azok elõállítására és alkalmazására
ZA201408856B (en) Heteroaryl compounds and methods of use thereof
IL233961A0 (en) The composition of a phytogenic supplement and methods of its use
PL2631024T3 (pl) Preformy odlewnicze oraz sposoby ich stosowania
ZA201408128B (en) Etract of greyia radlkoferi and use thereof
ZA201409322B (en) Injectable antibiotic formulations and their methods of use
GB201219328D0 (en) Game system and method of use thereof